TABLE 2.

Quantitative results of the effects among each experimental group demonstrating zebrafish inflammation (n = 10).

Group	Concentration (μg/mL)	Number of neutrophils (mean ± SE)	Anti-inflammatory effects (%)
Control	–	2 ± 0.29	–
LPS	–	18 ± 1.43	–
Indomethacin	28.6	12 ± 1.00∗∗∗	33∗∗∗
HLJDD	6.25	14 ± 1.53	22
	12.5	11 ± 1.13∗∗∗	39∗∗∗
	25	8 ± 0.96∗∗∗	56∗∗∗
	50	7 ± 0.95∗∗∗	61∗∗∗
	100	10 ± 1.58∗∗∗	44∗∗∗
Berberine	3.9	16 ± 1.64	11
	7.8	14 ± 1.00∗	22∗
	15.6	12 ± 0.73∗∗∗	33∗∗∗
	31.25	9 ± 1.05∗∗∗	50∗∗∗
	62.5	7 ± 0.88∗∗∗	61∗∗∗
Baicalin	15.6	17 ± 1.07	6
	31.25	13 ± 0.40∗∗∗	28∗∗∗
	62.5	10 ± 0.90∗∗∗	44∗∗∗
	125	9 ± 0.73∗∗∗	50∗∗∗
	250	8 ± 0.54∗∗∗	56∗∗∗
Geniposide	31.25	18 ± 1.34	0
	62.5	15 ± 1.23	17
	125	14 ± 0.70	22
	250	13 ± 1.62∗	28∗
	500	12 ± 0.96∗∗	33∗∗

^∗P < 0.05, ^∗∗P < 0.01, and ^∗∗∗P < 0.001, drug treatment group (or positive group) compared with LPS group.